In my role as Associate Editor for Translational Biology for the American Journal of Sports Medicine, I review a large number of papers using various animal models to test new biological therapies (''biologics''). Use of animals is, of course, a critical and necessary step for preclinical studies that need to be carried out before translating new therapies to human clinical trials. The specific animal model chosen is very important. A large number of animal species are used for our orthopaedic models, including rats, rabbits, dogs, sheep, mini-pigs, and goats. The choice of animal model used by an investigator is usually based on considerations related to cost; animal feeding, housing, and care; prior use of that specific model by other investigators; and feasibility for the proposed procedure. The specific purpose of the study is another critical consideration for the animal model chosen: Is the goal to test a realistic sized implant? Is it to carry out biomechanical testing? Is it to evaluate gene expression in the healing tissue? I will make some observations here about the limitations of currently used animal models and some thoughts for improving our animal models.
A fundamental deficiency of all animal models used for orthopaedic conditions is that most use an acute intervention to study tissues that are typically affected by a chronic, degenerative process. A good example is the lack of a realistic model of tendinosis. Painful tendinopathy is a common clinical problem for which we have few good solutions. Numerous different biological augmentation strategies have been evaluated in animal models. The most commonly used model uses collagenase to induce ''tendinosislike'' changes in the tendon. However, this is an acute insult to the tendon, which will be followed by a healing response. Furthermore, in small rodents there is a robust and rapid healing process, which differs significantly from the chronic, failed healing response that is seen in human tendinopathy. It is critical that we create ways to induce overuse changes in animal models that will mimic human pathologic conditions. Another very common model used is acute detachment and repair of a rotator cuff tendon in rats, rabbits, and sheep. Again, this does not mimic the human situation, where rotator cuff repair is typically performed in the setting of a degenerative tendon. Some investigators have tried to produce more of a chronic model by first detaching the tendon and then carrying out repair in a delayed fashion, more closely replicating the human condition. 3 Other common areas of translational research include models of articular cartilage repair and anterior cruciate ligament (ACL) reconstruction in the knee. Most cartilage injuries in our patients occur in the setting of early degenerative changes in the joint, with the associated alterations in inflammatory mediators, matrix metalloproteases, reactive oxygen species, and so on. The utility of these models could be improved with techniques that induce or simulate the inflammatory environment and biological milieu present in the human condition.
Perhaps one of the biggest deficiencies of essentially all animal models is the difficulty or inability to control the mechanical loading on the healing tissue. Authors will typically comment on the limitations attendant to using quadrupeds, where weightbearing is clearly different than in humans. In addition to the difference in weightbearing between bipedal and quadrupedal animals, a more fundamental limitation is the general inability to control weightbearing and joint motion postoperatively. Animal models are generally used to evaluate the biological events in tissue healing. We must recognize that the biomechanical forces on the healing tissue have a profound effect on the underlying biological response. It is surprising how infrequently investigators attempt to regulate and control the biomechanical loads on the healing tissue in the design of their animal model.
The lack of control of postoperative loading can almost become a ''fatal flaw'' or can invalidate several commonly used animal models. For example, we know that it is difficult to successfully stabilize the animal knee with ACL reconstruction. Although this is due to several factors, the inability to control joint motion and the lack of attention to graft isometry essentially result in a model of failed ACL reconstruction with recurrent knee laxity in many animal models. The resultant knee laxity can lead to stress deprivation of the graft, with relevant effects on mechanotransduction at the cellular level. Similarly, early detachment of the repaired rotator cuff tendon is known to occur in the commonly used sheep model of rotator cuff repair, due to the inability to protect the repair postoperatively. This essentially makes this a model of tissue formation in a gap, rather than a realistic model of rotator cuff tendon-to-bone healing. Finally, tissue formation in a cartilage defect treated with cell-based therapy is thought to be critically affected by loads on the healing tissue, and carefully designed progressive weightbearing regimens are used in our patients. The lack of such control of postoperative loading in animals is a clear deficiency that likely affects the biological mechanisms under study. Several approaches have been used in various animal models to control postoperative mechanical loads. Botulinum toxin can be used to temporarily paralyze the muscles of the rotator cuff to protect the healing tendon repair in the rat model. 2 Some investigators have used casts to try to immobilize the extremity. In my own laboratory we have designed and fabricated external fixators to use in the rat knee and the mouse knee. 1 In the sheep rotator cuff model, some investigators have tried affixing a large soft ball to the hoof to limit weightbearing. 4 Although these modalities allow some ability to control motion of a specific joint and/ or loads across a joint, none of these methods reproduce what occurs in humans. For example, placement of a ball on the hoof in sheep may actually lead to increased loads across the limb as the animal resists placement of the ball. Similarly, use of botulinum toxin to paralyze the muscle may well have other unintended physiologic effects due to the potential to interrupt or otherwise affect signals from the muscle that may affect tendon healing. Although external fixation of a joint will prevent joint motion, complete joint immobilization lacks clinical relevance since some degree of passive joint motion is typically done following tendon repair, while avoiding active motion. Clearly, we need innovative methods to precisely control the mechanical loading on the healing tissues in our animal models.
Ultimately, the primary purpose of an animal study is to provide information that will allow translation of basic science information to human clinical care. The translational value of animal models can be improved by using outcome measures that parallel those done in humans. We need to progress beyond the simple use of tissue evaluation with histologic and biomechanical testing. Incorporation of imaging methods such as magnetic resonance imaging (MRI), micro-computed tomography (CT), and ultrasound can parallel what is done in humans, making these models more translational. Specially designed coils can make MRI feasible in live animals, micro-CT can provide exquisite detail of bone architecture and microstructure, and new ultrasound techniques can provide rapid imaging data and parallel the imaging modalities that are used in patients. Development of new ways to image animals in vivo also allows repeat imaging in the same animal, which can decrease the number of animals needed, provide longitudinal assessment of changes over time, and mirror imaging evaluation that could be done in a human clinical trial.
Another area of outcome evaluation that will make our animal models more translational is to develop methods to assess in vivo pain and function. For example, new methods have been developed to quantify animal ambulation, with quantitative measurement of various gait parameters. Such methods can parallel measurements done in human patients. Ultimately, the combination of noninvasive imaging, measurements of animal function, and direct analysis of tissue structure, composition, and material properties will provide a comprehensive and robust analysis of outcome and will greatly improve the translational value of our animal models.
At the same time that we are striving to make our animal models more translational, I would also encourage development of mouse models of these commonly studied orthopaedic conditions. The mouse is a very powerful tool to examine basic cellular and molecular processes in tissue degeneration, healing, and regeneration. The availability of numerous transgenic strains provides the opportunity to test hypotheses related to the role of specific molecules, genes, proteins, and transcription factors on the biological process being investigated. Mouse models allow targeted deletion of a specific gene in a specific tissue at a specific time. The mouse also provides the ability to carry out cell lineage tracing, shedding light on the origin and identity of cells participating in healing.
In general, mouse models have been used only to study the biology of an ''induced injury,'' such as healing of a punch defect in a tendon, healing of a long bone fracture, or the progression of joint degeneration following destabilization of the meniscus. Very few investigators have used the mouse for ''reconstructive'' procedures, such as rotator cuff tendon repair or ACL reconstruction, largely due to technical complexity of carrying out microsurgical procedures in these very small joints. However, with the improvement in microsurgical techniques and instruments, such models are feasible. To be sure, this requires extensive practice to develop the technical expertise, along with an appropriate operating microscope or other surgical magnification devices and the proper instruments. However, the development of such models will open up the potential to take our studies of mechanisms of disease and healing to another level. Mouse models are the mainstay in many other areas of biomedical research, such as oncology and immunology, and it is time for orthopaedic surgeons to expand our horizons and consider the feasibility of using murine models.
At the same time that we try to use ''human-specific'' outcomes in our animals, I would encourage researchers to consider the feasibility of directly evaluating small tissue samples in patients. Can we use the ''human model'' as one more translational tool? I believe that the most effective translational research program will combine parallel human and animal studies. Let's try to make our animal models more like the human model and use our human models more like our animal models. The data from one can inform better approaches in the other, and such integration between preclinical and clinical studies should help move the field of ''biologics'' and ''regenerative medicine'' forward in a meaningful way. The findings from animal studies inform the design of clinical trials in patients, and the observations made in our clinical (human) trials aid development of hypotheses that can be tested in controlled animal models. This is the wellknown ''bench-to-bedside-to-bench'' approach. To the extent that the assays and outcome measures used in humans and animals can be similar, we will improve the utility and translational value of these studies. Image-guided small tissue biopsies in patients are now feasible, and laboratory techniques now allow detailed study of gene expression, tissue microstructure, and material properties at the microstructural level on these very small tissue samples.
In summary, it should be recognized that animal models are useful for evaluating safety of new biologics but are not as useful for testing efficacy. Ultimately, the most effective approach to evaluating new therapies and translating basic science data to human treatments may be a combined approach: using mice to examine molecular mechanisms; using a larger animal model to test a realistically sized implant, do realistic imaging, and assess function; and then using the human model, in which the postoperative conditions can be carefully controlled (ie, weightbearing, joint motion) and clinical outcomes can be measured. In this way we may be able to better integrate preclinical and clinical studies, improving the translation of our animal models to the human model. Scott A. Rodeo, MD New York, New York
